Nephrology & Urology Devices Market - Global Forecast 2025-2032

Senior decision-makers in the medical technology sector are navigating unprecedented change in the nephrology and urology devices market. Innovation, demographic trends, and evolving care models are reshaping product development and procurement strategies for hospitals, care centers, and suppliers alike.

Market Snapshot: Nephrology & Urology Devices Market Overview

The Nephrology & Urology Devices Market grew from USD 17.38 billion in 2024 to USD 19.36 billion in 2025. It is expected to continue growing at a CAGR of 11.12%, reaching USD 40.42 billion by 2032.

This dynamic environment is driven by rising chronic disease incidence, an aging population, and the shift toward patient-centric, cost-effective therapies. Stakeholders must balance regulatory compliance, supply chain stability, and operational excellence while investing in the latest device advancements.

Scope & Segmentation: In-Depth Market Coverage

The report offers a comprehensive analysis across all critical segments and regions for the nephrology and urology devices market.

• Product Types: Catheters, dialysis devices, endoscopes, lithotripsy devices, and ureteral stents.
• Dialysis Device Categories: Continuous renal replacement therapy systems, hemodiafilters, hemodialysis systems (for both home and in-center care), and peritoneal dialysis systems.
• Applications: Kidney failure management (continuous renal replacement therapy, hemodialysis, peritoneal dialysis), kidney stone removal (extracorporeal shock wave lithotripsy, laser lithotripsy), prostate disorders, and urinary incontinence management.
• End Users: Ambulatory surgical centers, dialysis centers, home care settings, and hospitals.
• Technologies: Acoustic wave, electrochemical, laser, and ultrafiltration technologies.
• Distribution Channels: Direct sales, distributors, and ecommerce platforms.
• Regional Coverage:
  • Americas: United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru.
  • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya.
  • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan.
• Key Companies: Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Asahi Kasei Corporation, Boston Scientific Corporation, Coloplast A/S, Teleflex Incorporated, Olympus Corporation, Cook Medical LLC.

Key Takeaways for Decision-Makers

• Growth in home-based care and minimally invasive therapies is accelerating, with device designs focusing on ease of use, portability, and improved patient recovery times.
• Digital health integration, such as remote monitoring and AI-assisted imaging, is enabling proactive care and operational efficiencies across both hospital and home settings.
• Regulatory and reimbursement changes demand robust clinical validation and clear evidence of patient-reported outcomes for new product introductions.
• Supply chain resilience is a top priority as recent tariffs on materials and components have impacted procurement, inventory strategies, and lead times for global manufacturers.
• Segmentation reveals that demand patterns are not uniform; modality-specific solutions and technological customization are increasingly essential to meet diverse care environment needs.
• Collaboration between corporate players, academic partners, and regional suppliers is advancing innovation pipelines and supporting competitive differentiation throughout the nephrology and urology devices market.

Tariff Impact: Supply Chain and Pricing Strategies

United States tariffs introduced in 2025 have disrupted sourcing and increased costs for raw materials, surgical components, and polymers. Manufacturers are negotiating new supplier agreements, exploring domestic production, and refining commercial models to sustain competitive pricing and supply chain continuity. Hospitals, home care providers, and procurement executives are responding by renegotiating contracts and adopting bundled or flexible purchasing plans, placing emphasis on total cost of ownership and value-added services.

Methodology & Data Sources

This analysis combines primary interviews with clinical, regulatory, and procurement leaders, alongside structured manufacturer surveys. Secondary data from journals, regulatory documents, company filings, and industry reports validates key trends. An expert panel reviewed and refined findings through a structured workshop, ensuring actionable and reliable insights for strategic planning.

Why This Report Matters

• Enables strategic investment and commercialization decisions by outlining segment priorities and disruptive trends.
• Guides supply chain and procurement leaders to anticipate cost drivers, optimize sourcing, and maintain operational agility.
• Supports regulatory and product management teams with insights into shifting compliance and evidence standards.

Conclusion

The nephrology and urology devices market is transforming through rapid technological progress, regulatory updates, and new care models. With targeted insights and detailed segmentation, this report equips leaders to sustain growth, enhance patient outcomes, and build competitive strategies for future success.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.